AZD1222 was developed by Oxford University and licensed to AstraZeneca, which has put it into large-scale, late-stage trials to test its efficacy. CanSino vaccine also shows promiseMore than 150 possible vaccines are in various stages of development, with U.S. drugmaker Pfizer and China's CanSino Biologics also reporting positive responses for their candidates on Monday. WATCH | CanSino vaccine candidate to be used by Chinese military:A vaccine developed by a Chinese company in collaboration with the Canadian government will skip a final phase of testing and will be used on Chinese soldiers. Bar-Zeev and Moss also called for any effective COVID-19 vaccine to be distributed equitably around the world. The vaccine being developed by Pfizer also works to trigger a similar dual immune response as the Oxford shot.

Source: CBC News July 20, 2020 17:26 UTC